2 
Acfcninistraticx\; Sue Tblin, U.S. Department of Agriculture; and William J. 
Walsh, III, U.S. Department of State. 
Other Nationad Institutes of Health staff present were ; 
Stanley Barbem, NIAID; W. Elrmett Barkley, ORS; Becky Connors, NIAID; Irving 
Delappe, NIAID; Richard Krause, NIAID; Elizabeth Milewski, NIAID; Stanley 
Nagle, NIAID; John Nutter, NIAID; Bernard Talbot, NIAID; John Venditti, NCI; 
Michael H. \Ax3kin, NIAID; and Rudolf Wanner, ORS. 
Others in attendance for all or part of the meeting were ; 
Robert Banks, RAND Corporation; Tineke Bodde, BioScience Magazine; Irene Brandt, 
Eli Lilly & Co.; Meredith Broadbent; Joel M. Dedrynple, USAMRIID; Mary Ann 
Danello, Amer. Assoc, for the Advancement of Science and American Society for 
Microbiology; Mark DeOries, Cenex Corporation; David Dickson, Nature; Paula Dwyer, 
McGraw-Hill; Mark Finkelstein, Schering-Plough Corporation; Charles Gaush, Bethesda 
Research Laboratories; Pat Germann, Cenex Corporation; Zsolt Harscinyi, DNA Science, 
Inc.; Clayton Hathaway, Monsanto Ccnpany; Judith Hautala, Cenex Corporation; Leslie 
Henderson, Uhiversity of Missouri; Holly Hexter, Higher Education Daily; Philip 
Hilts, Washington Post; Jerry Hunter, Uhiversity of Maryland; Evelyn Hurlburt, 
Johns Hopkins School of Medicine; Dorothy Jessup, U.S. Department of Agriculture; 
J. A. Johnson, Library of Congress; M. J. Johnson, Pall Corporation; Attila I. 
Kadar, Pood and Drug Administration; Geoffrey Kamy, Office of Technology Assess- 
ment; Michael Konrad, Cetus Corporation; Howard Koonse, Fort Dodge Laboratories; 
Paul Leibowitz, Schering-Plough Corporation; Carter Leonard, Blue Sheet; Morris 
A. Levin, Environmental Protection Agency; Dan Liberman, Massachusetts Institute 
of Technology; Max Marsh, Eli Lilly & Company; James McCullough, Library of 
Congress; Kim McDonald, Chronicid of Higher Education; Julia Miller, Science News; 
Claire Nader; Nanette Newell, Office of Technology Assessment; Norine Noonaui, 
Science and Itechnology Ccnuittee, House of Representatives; Ann Norberg, Monsanto 
Co.; Lacy Overby, Abbott Laboratories; C. J. Peters, USAMRIID; Stephen Pi jar. Food 
and Drug Administration; William Pilacinski, Molecular Genetics, Inc.; Michael . 
Ross, Genentech, Inc.; Michael Ryan, Sobering Corporation; John Salstein, Molecular 
Genetics, Inc.; Jim Silvenran, Stauffer Chemical; Stephanie Soucek, National 
Institute for Occupational Safety & Health; Laurence Storch; J. H. Stryh, President's 
Ccmmission; Donna Suchmann, Hazelton Laboratories; Charles Turbyville, NIH We^; 
Robert Willette, DUO Research; Susan Wright, Uhiversity of Michigan; and Burke 
Zimmenran, George Washington University. 
[1931 
